The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. Reuters/Luke MacGregor/File Photo The line between pharmaceuticals and technology is blurring as companies join forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware. Glax...





